A former Harvard University scientist convicted of lying to federal investigators about his ties to China has established a new brain-computer interface laboratory in Shenzhen, according to documents reviewed by Reuters.
The case illuminates the intensifying technology competition between Washington and Beijing, particularly in sensitive dual-use technologies with potential military applications. Brain-computer interfaces—systems that enable direct communication between the brain and external devices—represent a critical frontier in both medical treatment and defense capabilities.
Charles Lieber, once chair of Harvard's chemistry department, was convicted in December 2021 on charges including making false statements to federal authorities about his participation in China's Thousand Talents Program. The program, launched by Beijing in 2008, offers substantial financial incentives to recruit overseas scientists, particularly in fields deemed strategically important.
Federal prosecutors alleged Lieber received $50,000 monthly payments from Wuhan University of Technology and $150,000 in living expenses, while simultaneously receiving millions in grants from U.S. defense and health agencies. He denied the Chinese affiliation to investigators.
Now, according to Chinese corporate filings, Lieber has resumed research activities through a laboratory registered in Shenzhen. The facility focuses on nanoscale electronics and neural interface technologies—precisely the expertise that made him a recruitment target.
"Watch what they do, not what they say. In East Asian diplomacy, the subtext is the text," applies equally to the U.S.-China technology competition. While both nations publicly emphasize scientific cooperation and academic freedom, the underlying reality is a systematic effort to dominate emerging technologies with military significance.
Brain-computer interfaces have applications ranging from treating paralysis to controlling weapons systems. The U.S. Defense Advanced Research Projects Agency (DARPA) has invested heavily in the technology, as has China's People's Liberation Army research apparatus.
The Lieber case is one of dozens prosecuted under the Department of Justice's "China Initiative," launched in 2018 to counter economic espionage and technology transfer. While the program was formally ended in 2022 amid criticism that it encouraged racial profiling of Asian-American scientists, prosecutions of alleged technology theft continue.
For Beijing, recruiting scientists like Lieber serves a dual purpose: acquiring cutting-edge knowledge and signaling that China offers opportunities unavailable in the West. The Thousand Talents Program has reportedly recruited more than 7,000 overseas experts, though China has become less transparent about the initiative following international scrutiny.
The semiconductor industry provides a parallel. After the U.S. restricted China's access to advanced chipmaking equipment, Beijing intensified efforts to recruit Taiwanese and South Korean engineers with TSMC and Samsung experience. The pattern is consistent: when direct technology access is blocked, pursue the human talent.
Lieber's new laboratory operates in Shenzhen, the southern boomtown that has become China's answer to Silicon Valley. The city hosts major technology firms including Huawei and Tencent, and has positioned itself as a hub for advanced manufacturing and research.
The timing is notable. As the U.S. tightens export controls on AI chips and quantum computing technology, China is accelerating investment in adjacent fields where it can still access global expertise. Brain-computer interfaces, synthetic biology, and advanced materials represent areas where the technological gap is narrower.
From a regional perspective, Japan and South Korea watch these developments with particular concern. Both nations face pressure to align their technology export controls with U.S. policy, even as they maintain substantial economic ties with China. The Lieber case demonstrates that technology competition increasingly transcends traditional trade or military boundaries.
The U.S. sentenced Lieber to time served plus six months of house arrest in 2023, a relatively light sentence that prosecutors attributed to his health conditions. His ability to establish a new laboratory in China raises questions about the effectiveness of current mechanisms to prevent technology transfer in strategic sectors.
Neither Lieber nor the Shenzhen laboratory responded to requests for comment. Harvard University declined to comment on his current activities.
